Sign up
Healthed-White-on-Blue

Beclometasone/ formoterol/ glycopyrronium pMDI for maintenance treatment of moderate to severe COPD

Description

In this Product Explainer, Dr Philip Lee explains the role of beclomethasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment of adults with moderate to severe COPD who are not adequately treated by ICS/LABA or LABA/LAMA (7 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Sushil Pant

Dr Sushil Pant

Acutely Painful Shoulder – Assessment and Management in GP

Dr Richard Phoon

Dr Richard Phoon

Chronic Kidney Disease – Delay Progression and Prevent Dialysis

Prof Rodney Baber AM

Prof Rodney Baber AM

Understand & Explain the Risks & Side Effects of MHT

Prof Peter Richmond

Prof Peter Richmond

Invasive Pneumococcal Disease – What GPs Need to Know

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

14 October 2025
Register Now
Dr Philip Lee

expert

Dr Philip Lee

Respiratory and Sleep Physician; Consultant, Respiratory and Sleep Medicine, St George and Northern Beaches Hospitals

Date published: 14 August 2024

Education by clinicians, for clinicians

Get the app

Site

Company

Connect

Legal

Discover

Healthed

CPD platform